Ifp Advisors, Inc Nutri Band Inc. Transaction History

Ifp Advisors, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	BUY	$3.49 - $7.83 $118 - $266	34 Added 17.0%	234 $8,000
Q2 2022 Sep 06, 2022	BUY	$2.81 - $5.69 $562 - $1,138	200 New	200 $7,000
Q2 2022 Aug 12, 2022	SELL	$2.81 - $5.69 $562 - $1,138	-200 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$3.3 - $9.43 $660 - $1,886	200 New	200 $0

284K

Ticker NTRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,803,260
Market Cap $34.2M
Description
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid the...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.